These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20616548)

  • 1. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Saggi SJ; Salifu MO
    Cardiology; 2010; 116(3):157-9. PubMed ID: 20616548
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Fink JC; Lodge MA; Smith MF; Hinduja A; Brown J; Dinits-Pensy MY; Dilsizian V
    Cardiology; 2010; 116(3):160-7. PubMed ID: 20606430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904
    [No Abstract]   [Full Text] [Related]  

  • 4. Early origins of cardiovascular disease in pediatric chronic kidney disease.
    Patel HP
    Ren Fail; 2010 Jan; 32(1):1-9. PubMed ID: 20113258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Images in cardiovascular medicine. Hibernating myocardium identified by cardiovascular magnetic resonance and positron emission tomography.
    Tadamura E; Yamamuro M; Kubo S; Kanao S; Harada M; Nakao K; Komeda M; Togashi K
    Circulation; 2006 Feb; 113(7):e158-9. PubMed ID: 16490827
    [No Abstract]   [Full Text] [Related]  

  • 6. Albuminuria as early test for vascular disease.
    Remuzzi G; Weening JJ
    Lancet; 2005 Feb 12-18; 365(9459):556-7. PubMed ID: 15708086
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic kidney disease as cause of cardiovascular morbidity and mortality.
    Vanholder R; Massy Z; Argiles A; Spasovski G; Verbeke F; Lameire N;
    Nephrol Dial Transplant; 2005 Jun; 20(6):1048-56. PubMed ID: 15814534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular and extracellular targets of molecular imaging in the myocardium.
    Chun HJ; Narula J; Hofstra L; Wu JC
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S33-41. PubMed ID: 18641605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elderly with advanced chronic kidney disease.
    Abutaleb N
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):156-8; author reply 158-9. PubMed ID: 21196638
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT.
    Wong KK; Tolia B; Bohnen N
    Clin Nucl Med; 2008 Jun; 33(6):443-4. PubMed ID: 18496462
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic nephropathies as cardiovascular risk factors. Reports of the American Heart Association and of the Third National Health and Nutrition Examination Survey].
    Recenti Prog Med; 2004; 95(7-8):400-1. PubMed ID: 15303553
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid metabolism and causal pathways for cardiovascular disease in chronic kidney disease.
    van Heyningen C
    Curr Opin Lipidol; 2009 Oct; 20(5):440-1. PubMed ID: 19741339
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical cardiovascular molecular imaging.
    Bengel FM
    J Nucl Med; 2009 Jun; 50(6):837-40. PubMed ID: 19443581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease.
    Soussan M; Sberro R; Wartski M; Fakhouri F; Pecking AP; Alberini JL
    Ann Nucl Med; 2008 Jul; 22(6):529-31. PubMed ID: 18670861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease and chronic kidney disease: insights and an update.
    Best PJ; Reddan DN; Berger PB; Szczech LA; McCullough PA; Califf RM
    Am Heart J; 2004 Aug; 148(2):230-42. PubMed ID: 15308992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Images in cardiovascular medicine. Diagnosis of large-vessel vasculitis by [18F] fluorodeoxyglucose-positron emission tomography.
    Neumann T; Oelzner P; Freesmeyer M; Hansch A; Opfermann T; Hein G; Wolf G
    Circulation; 2009 Jan; 119(2):338-9. PubMed ID: 19153285
    [No Abstract]   [Full Text] [Related]  

  • 17. Prehypertension and prechronic kidney disease: fact or fiction?
    Ribitsch W; Rosenkranz AR
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):651-3. PubMed ID: 21714594
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiorenal syndrome and later-onset Fabry disease: is there a connection?
    Bzduch V
    Bratisl Lek Listy; 2007; 108(4-5):169. PubMed ID: 17694798
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical challenges: the intersection of diabetes, chronic kidney disease, and cardiovascular disease.
    Nass CM; Reck K
    Curr Diab Rep; 2004 Feb; 4(1):1-2. PubMed ID: 14764271
    [No Abstract]   [Full Text] [Related]  

  • 20. New strategies to prevent cardiovascular risk in chronic kidney disease.
    Luño J; Remuzzi G; Rodriguez-Iturbe B; Ayus JC
    Kidney Int Suppl; 2008 Dec; (111):S1. PubMed ID: 19034317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.